Optigenex Inc. Announces Expansion of AC-11(R) Sales in Japan Through Its Exclusive Partner Itochu Corporation

NEW YORK, NY, Feb 03 (MARKET WIRE) --
Optigenex Inc. (PINKSHEETS: OPGX) announced today the introduction of
AC-11(R)-melon, a new oral capsule formulated by its partner, Itochu
Corporation, utilizing patented AC-11(R) in combination with GliSODin, a
cantaloupe melon extract rich in the vegetable antioxidant enzyme (SOD).
The protective benefits of GliSODin, in conjunction with the therapeutic
benefits of AC-11(R) to help repair naturally the body's damaged DNA,
offer a unique and highly effective combination for cellular wellness to
health-conscious consumers*. Japan traditionally has been known for its
highly educated and well-informed consumer population, especially in the
area of healthy aging. The enthusiastic response to Koyo-sa Japan's
rollout of AC-11(R)-melon validates this reputation and constitutes
another step forward in the evolution of AC-11(R) as one of the most
popular health and wellness technologies in Japan.

Itochu acts in partnership with Optigenex under a Long-Term Exclusive
Supply and Trademark Licensing Agreement to market AC-11(R) bulk material
and consumer products containing AC-11(R) under sublicenses in Japan and
several other Asian countries. To date, the company has introduced
AC-11(R) successfully to over 110 companies in the cosmetic and dietary
supplement market, with 130 plus products containing AC-11(R) currently
being marketed and sold in Japan. AC-11(R) is the patented, all-natural
rain forest botanical extract produced by Optigenex that helps the body's
natural ability to repair damage to DNA due to multiple causes, including
harmful effects of UV radiation (over-exposure to the sun), stress,
environmental pollution and other stressors. In its standard bulk powder
form, AC-11(R) supplement may be consumed orally or combined with
liposomes and other delivery mechanisms for topical application to the
skin.

Daniel Zwiren, president and CEO of Optigenex Inc., said, "We are excited
about the Koyo-sa's new product and anticipate further expanded growth in
sales this year of AC-11(R) to Japan, not only for AC-11(R)-melon but for
other AC-11(R) nutraceutical products as our message for cellular wellness
and healthy aging continues to take hold with our customers."

Yusuke Itou of Itochu Corporation added, "Koyo-sa is the largest network
marketing company in Japan. We are extremely pleased that they have
decided to market AC-11(R)-melon and that they recognize the importance of
combining synergistic ingredients for new and robust products." Mr. Itou
continued, "We fully expect to augment sales and volume of bulk purchases
significantly in 2010 and beyond as our customers integrate AC-11(R) into
existing products and formulate new products utilizing AC-11(R) as the
main ingredient."

About ITOCHU Corporation:

Itochu Corporation is one of Japan's leading trading companies and is
engaged in a wide variety of businesses, including food products, personal
care products, textiles, technology multimedia, metals, energy, chemicals,
forest products, retail and financial services. Itochu has approximately
45,690 employees, maintains over 130 offices and owns over 651
subsidiaries and affiliates around the world. Itochu's sales last year
reached 11.58 trillion yen (U.S. $95 billion).

About Optigenex Inc.:

Optigenex Inc. is a formulator, distributor and provider of proprietary
next generation skin care, supplements and bulk ingredient featuring as
its core product AC-11(R) (formerly known as C-MED-100(R)) a patented,
bioactive and water soluble rain forest compound derived from the
medicinal herb Uncaria tomentosa. For more information about Optigenex
please visit our website: www.optigenex.com

*The statements made in this press release have not been evaluated by the
Food and Drug Administration (FDA). The products mentioned herein are not
intended to diagnose, treat, cure or prevent any disease.

Contact:
Optigenex Inc.
Dan Zwiren
president and CEO Optigenex Inc.
dzwiren@optigenex.com
201 355 2098

Copyright 2010, Market Wire, All rights reserved.

-0-